Etoposide in short supply

Tuesday, 14 Feb 2017


Etopophos etoposide 1 g (as phosphate) and Etopophos etoposide phosphate 113.6 mg (equivalent to 100 mg etoposide) powder for injection vials and Vepesid etoposide 50 mg capsule blister packs are in short supply, the TGA has advised.

The affected products are:

ARTG No ARTG Label Sponsor Status
57483 Etopophos etoposide phosphate 113.6 mg (equivalent to 100 mg etoposide) powder for injection vial Bristol-Myers Squibb Australia Unavailable until 1 April 2017
77220 Etopophos etoposide 1 g (as phosphate) powder for injection vial Bristol-Myers Squibb Australia Unavailable until 1 April 2017
10233 Vepesid etoposide 50 mg capsule blister pack Bristol-Myers Squibb Australia Out of stock from 28 February 2017 until 1 April 2017
10234 Vepesid etoposide 100 mg capsule blister pack Bristol-Myers Squibb Australia Available

A previous shortage of Vepesid etoposide 100 mg capsule blister pack has been resolved.

Clinicians are asked to take the shortages into account when planning treatment with Etopophos injection vials or Vepesid capsules. For more information the TGA advises health professionals to contact the drug sponsor.

 

 

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic